StudyRareStudyRare

Metabolic Disorders

77 conditions|27 ABGC-listed

Overview

Metabolic disorders encompass inborn errors of metabolism affecting amino acids, organic acids, fatty acids, carbohydrates, lysosomes, peroxisomes, and mitochondria. Key concepts include newborn screening, acute metabolic crises, and substrate reduction/enzyme replacement therapies.

Amino acid disorders

Amino acid disorders disrupt the breakdown of amino acids, causing toxic accumulation. Most are on newborn screening. Key presentations: PKU (untreated → ID, musty odor; maternal PKU is critical), MSUD (maple syrup odor, encephalopathy), homocystinuria (downward lens dislocation - opposite of Marfan, thrombosis), and tyrosinemia type 1 (liver failure, succinylacetone is pathognomonic). NKH presents with severe neonatal seizures and elevated CSF glycine.

Organic acidemias

Organic acidemias present with metabolic acidosis, hyperammonemia, and ketosis - often in the neonatal period. MMA and propionic acidemia are clinically similar (both from branched-chain amino acid metabolism), but MMA can be B12-responsive. Isovaleric acidemia has the classic "sweaty feet" odor. Glutaric aciduria type 1 causes macrocephaly and acute dystonia after illness - the MRI shows "bat wings."

Carnitine cycle disorders

The carnitine cycle is the four-step entry system that gets long-chain fatty acids from the cytosol into the mitochondrial matrix: OCTN2 imports carnitine into the cell (carnitine uptake defect), CPT1 conjugates a long-chain fatty acid to carnitine on the outer mitochondrial membrane, CACT translocates the acylcarnitine across the inner membrane, and CPT2 regenerates acyl-CoA on the matrix side. Defects at any step block long-chain FAO. Acylcarnitine signatures: low C0 in CUD, high C0 in CPT1A, elevated C16/C18 species in CACT and CPT2 (indistinguishable on NBS). Phenotype severity scales with where in the cycle the block sits: CUD is the most treatable (oral carnitine), CACT is the most lethal, and CPT2 has a recognizable adult-onset myopathic form with exercise-, cold-, and fasting-induced rhabdomyolysis.

Beta-oxidation enzyme defects

Beta-oxidation is the spiral of four reactions that shortens fatty acyl-CoAs by two carbons per cycle. Chain-length-specific dehydrogenases handle each segment: SCAD (C4-C6), MCAD (C6-C12), VLCAD (C14-C20), and the trifunctional protein/LCHAD (long-chain hydroxy-step). All present with hypoketotic hypoglycemia (the body cannot use fat for energy during fasting). MCAD is the most common and clinically central; it is on newborn screening and presents with hypoketotic hypoglycemia during fasting or illness. VLCAD and LCHAD/TFP are more severe with cardiac involvement; LCHAD/TFP are distinctive for peripheral neuropathy, retinopathy, and maternal HELLP/AFLP. SCAD is largely an NBS incidentaloma with uncertain clinical significance. MADD (glutaric aciduria type II) is a special case that blocks every acyl-CoA dehydrogenase at once through an upstream electron-transfer defect (ETF/ETFDH); the late-onset form is often riboflavin-responsive.

Carbohydrate metabolism

Galactosemia presents in the first week of life with E. coli sepsis, cataracts, and liver failure after starting milk feeds - it's on newborn screening but symptoms may appear before results. Hereditary fructose intolerance presents when fructose is introduced. Glycogen storage diseases vary by which organ is affected: GSD1 (liver - severe hypoglycemia), GSD2/Pompe (muscle/heart - ERT available), GSD5/McArdle (muscle only - "second wind" phenomenon).

Lysosomal storage - Sphingolipidoses

Sphingolipidoses accumulate complex membrane lipids. Distinguishing features cluster by ethnicity and physical signs: Gaucher (Ashkenazi Jewish, bone crises, GBA1-related Parkinson risk), Fabry (X-linked, acroparesthesias, angiokeratomas, renal/cardiac involvement), Tay-Sachs and the GM2 gangliosidoses (cherry-red macula, neurodegeneration; Ashkenazi founder in Tay-Sachs), Niemann-Pick (A = infantile + cherry-red; B = HSM + lung; C = vertical gaze palsy), Krabbe and MLD (leukodystrophy + peripheral neuropathy; Krabbe on RUSP). Enzyme replacement therapy is available for many.

Sphingolipidoses summary: enzymes, genes, accumulated substrate, organ involvement, and neurologic features for Fabry, Gaucher, Tay-Sachs, Krabbe, MLD, and Niemann-Pick A/B/C
Sphingolipidoses summary: enzymes, genes, accumulated substrate, organ involvement, and neurologic features for Fabry, Gaucher, Tay-Sachs, Krabbe, MLD, and Niemann-Pick A/B/C

Lysosomal storage - Mucopolysaccharidoses

The four MPSs store glycosaminoglycans and are easiest to remember by sound: MPS I = "Hur1er", MPS II = "Hun-Two-er" (Hunter), MPS III = "SanfIIIppo", MPS IV = "MorQUio" (QUad = 4). Hunter (MPS II) is the only X-linked MPS and the only one without corneal clouding (vs. MPS I Hurler, which has it). Morquio (MPS IV) spares cognition but causes severe skeletal dysplasia and odontoid hypoplasia. Sanfilippo (MPS III) is the CNS-predominant form. Each MPS enzyme either removes sulfur ("-sulfatase") or removes a saccharide ("-idase", e.g., iduronidase, glucosaminidase). ERT is available for several.

MPS types and their enzymes: sulfatases (red) vs -idase enzymes (yellow)
MPS types and their enzymes: sulfatases (red) vs -idase enzymes (yellow)

Memory aid:MPS types I-IX song (2 min mnemonic)

Lysosomal storage - Lipid storage

Lipid-storage LSDs outside the classic sphingolipidoses. Wolman disease (LIPA, lysosomal acid lipase deficiency) presents in infancy with hepatosplenomegaly, failure to thrive, and bilateral adrenal calcifications on imaging.

Lysosomal storage - Other

Conditions that do not fit the sphingolipid or MPS categories. I-cell disease (mucolipidosis II, GNPTAB) presents with Hurler-like coarse features, gingival hyperplasia, and severe joint restriction. Neuronal ceroid lipofuscinosis (Batten disease, CLN3 and others) presents with progressive vision loss, refractory seizures, and cognitive decline in childhood.

Peroxisomal disorders

Peroxisomal disorders affect fatty acid metabolism and plasmalogen synthesis. X-ALD (ABCD1) is on newborn screening - the childhood cerebral form is devastating but HSCT can help if caught early. The Zellweger spectrum represents peroxisome biogenesis defects (PEX genes) - severe forms present with hypotonia, seizures, and characteristic facies. Elevated VLCFA is the screening test for most. Refsum disease is treatable with dietary phytanic acid restriction.

Mitochondrial disorders

Mitochondrial disorders affect energy production and can be caused by mtDNA or nuclear genes. Key features: maternal inheritance (mtDNA), heteroplasmy, and multi-organ involvement (especially brain, muscle, heart). MELAS (stroke-like episodes + lactic acidosis), MERRF (myoclonic epilepsy + lipomas), and Leigh syndrome (basal ganglia lesions on MRI) are classic presentations. POLG variants + valproate = fatal hepatotoxicity.

Other metabolic

This section covers conditions that don't fit neatly elsewhere. Cobalamin C deficiency (cblC, MMACHC) sits at the intersection of organic-acid and remethylation pathways: combined methylmalonic acidemia + homocystinuria, retinopathy, and megaloblastic anemia. PMM2-CDG (a congenital disorder of glycosylation) has the characteristic inverted nipples and abnormal fat pads. Alkaptonuria is benign until adulthood when ochronosis (dark cartilage) and arthritis develop - dark urine is the clue. Acute intermittent porphyria presents with acute attacks of abdominal pain, neuropsychiatric symptoms, and NO photosensitivity (distinguishing it from other porphyrias).

Summary Table

DisorderGeneInheritanceCardinal Features
PKUPAHARID if untreated, maternal PKU syndrome, on RUSP
MSUDBCKD genesARMaple syrup odor, encephalopathy, on RUSP
HomocystinuriaCBSARDownward ectopia lentis, thrombosis, marfanoid
Tyrosinemia IFAHARLiver failure, succinylacetone, HCC risk, on RUSP
NKHGLDC, AMTARNeonatal encephalopathy, intractable seizures, elevated CSF glycine
Hyperprolinemia IPRODHARUsually benign; elevated proline; 22q11.2 region
Pyridoxine-dependent epilepsyALDH7A1ARRefractory neonatal seizures, dramatic response to B6
OTC deficiencyOTCXLRHyperammonemia, orotic aciduria, males severe
Arginase deficiencyARG1ARSpastic paraparesis, mild hyperammonemia, high arginine
ASL deficiencyASLARHyperammonemia, trichorrhexis nodosa, argininosuccinic acid
MMAMUT, MMAAARMetabolic acidosis, hyperammonemia, B12-responsive forms, on RUSP
Propionic acidemiaPCCA, PCCBARAcidosis, hyperammonemia, cardiomyopathy, on RUSP
Cobalamin C (cblC)MMACHCARMMA + homocystinuria, retinopathy, megaloblastic anemia
Isovaleric acidemiaIVDAR"Sweaty feet" odor, acute crises, on RUSP
Glutaric aciduria 1GCDHARMacrocephaly, acute dystonia, "bat-wing" MRI, on RUSP
CanavanASPAARLeukodystrophy, macrocephaly, elevated NAA, AJ founder
Carnitine uptake defectSLC22A5ARDCM, hypoglycemia, very low plasma carnitine (low C0), on RUSP
CPT1ACPT1AARHepatic-only phenotype, high C0 (free carnitine), Inuit founder variant
CACTSLC25A20ARNeonatal cardiomyopathy, arrhythmia, often lethal
CPT2CPT2ARAdult myopathic form: rhabdo with exercise/cold/fasting; severe neonatal form resembles CACT
MCADDACADMARHypoketotic hypoglycemia, avoid fasting, C8 on NBS, on RUSP
VLCADDACADVLARHypoketotic hypoglycemia, cardiomyopathy, C14:1, on RUSP
LCHADD / TFPHADHA, HADHBARCardiomyopathy, peripheral neuropathy, retinopathy, maternal HELLP/AFLP, C16-OH, on RUSP
SCADDACADSARUncertain phenotype; elevated C4, EMA on urine; removed from many state NBS panels
MADD / GA-IIETFA, ETFB, ETFDHARPan-elevation of acylcarnitines; late-onset form is riboflavin-responsive
GalactosemiaGALTARE. coli sepsis, cataracts, ovarian failure, on RUSP
Hereditary fructose intoleranceALDOBARHypoglycemia after fructose; aversion to sweets
GSD1G6PCARSevere hypoglycemia, hepatomegaly, lactic acidosis
Pompe (GSD II)GAAARCardiomegaly, hypotonia, ERT available, on RUSP
GSD III (Cori)AGLARHepatomegaly, milder hypoglycemia, myopathy, elevated CK
GSD V (McArdle)PYGMARExercise intolerance, "second wind", myoglobinuria
SLOSDHCR7AR2-3 toe syndactyly, ID, genital anomalies; elevated 7-DHC
CTXCYP27A1ARJuvenile cataracts, tendon xanthomas, neurodegeneration; treatable
Familial hypercholesterolemiaLDLR, APOB, PCSK9ADElevated LDL from birth, tendon xanthomas, premature ASCVD
GaucherGBA1ARHepatosplenomegaly, bone disease, Ashkenazi Jewish
FabryGLAXLRAcroparesthesias, angiokeratomas, renal/cardiac
Tay-SachsHEXAARCherry-red spot, neurodegeneration, Ashkenazi Jewish
GM2 (Sandhoff)HEXB, GM2AARTay-Sachs-like + visceromegaly (Sandhoff); startle, cherry-red spot
Niemann-PickSMPD1, NPC1/2ARA: infantile + cherry-red; B: HSM/lung; C: vertical gaze palsy
KrabbeGALCARInfantile leukodystrophy, peripheral neuropathy, on RUSP
MLDARSAARLeukodystrophy + peripheral neuropathy; late infantile to adult
MPS I (Hurler)IDUAARCoarse features, corneal clouding, dysostosis
MPS II (Hunter)IDSXLRLike MPS I but NO corneal clouding, pebbled skin
MPS III (Sanfilippo)SGSH, othersARPredominantly CNS, behavioral problems; mild somatic
MPS IV (Morquio)GALNS, GLB1ARSkeletal dysplasia, normal IQ, odontoid hypoplasia
NCL (Batten)CLN3, othersARProgressive vision loss, seizures, cognitive decline
I-cell diseaseGNPTABARHurler-like, gingival hyperplasia, restricted joints
WolmanLIPAARHepatosplenomegaly, adrenal calcifications, FTT
X-ALDABCD1XLRCerebral ALD in boys, elevated VLCFA, on RUSP
Zellweger spectrumPEX genesARHypotonia, seizures, dysmorphism, elevated VLCFA
RefsumPHYH, PEX7ARPhytanic acid, RP, neuropathy, ataxia; diet-treatable
RCDPPEX7, GNPAT, AGPSARRhizomelic shortening, stippled epiphyses, cataracts
FAR1-relatedFAR1AR/ADCataracts, ID, seizures; plasmalogen deficiency
MELASmtDNAMaternalStroke-like episodes, lactic acidosis
MERRFMT-TKMaternalMyoclonic epilepsy, ragged red fibers, lipomas
NARPMT-ATP6MaternalNeuropathy, ataxia, RP; Leigh at high heteroplasmy
Leigh syndromemtDNA/nuclearVariableSubacute necrotizing encephalomyelopathy, BG lesions
mtDNA DeletionsmtDNASporadicPearson, Kearns-Sayre, CPEO spectrum
POLG-relatedPOLGARAlpers, PEO; VALPROATE contraindicated (hepatotoxic)
MNGIETYMPARGI dysmotility, cachexia, PEO, leukoencephalopathy
PDH deficiencyPDHA1, othersXLD/ARLactic acidosis, normal L:P ratio, brain malformations
Barth syndromeTAFAZZINXLRDCM, neutropenia, skeletal myopathy
Lesch-NyhanHPRT1XLRSelf-injurious behavior, choreoathetosis, hyperuricemia
ADA-SCIDADAARSCID (T-B-NK-), costochondral abnormalities, on RUSP
AIPHMBSADAbdominal pain, neuropsychiatric, no photosensitivity
AlkaptonuriaHGDARDark urine, ochronosis, arthritis
PMM2-CDGPMM2ARInverted nipples, abnormal fat pads, cerebellar hypoplasia
MTHFRMTHFRCommon variantMild hyperhomocysteinemia with low folate; testing rarely indicated